Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects on Insulin Secretion and Sensitivity of Two Different Formulations Tacrolimus - Prograf® and Advagraf®

NCT01092806 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.

NCT NCT01092806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01092806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects on Insulin Secretion and Sensitivity of Two Different Formulations Tacrolimus - Prograf® and Advagraf®
Lead sponsor
University of Oslo School of Pharmacy
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
May 31, 2010
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post transplant diabetes mellitus